Dimethyl (2-oxo-3-phenoxypropyl)phosphonate, 95.0%, 5g

2-Chloro-n-(pyrimidin-2-yl)propanamide, 95%, 5g

1-(4-Chlorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)propane-1,3-dione, 97.0%, 1g

Olopatadine Hydrochloride, >98.0%(HPLC)(T), 25g

4-Oxo-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, 90.0%, 10g

DABRAFENIB MESYLATE, 95%, 250mg

2,4-Dibromo-5-fluoroaniline, 95.0%, 5g

5-BROMOBENZOTHIAZOLE-2-CARBOXYLIC ACID, 95.0%, 50mg

(11bS)-N-Benzyl-N-methyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98.0%, 100mg

N-(2,2-Dimethoxyethyl)-3-nitropyridin-2-amine, 97.0%, 250mg

Colonne capillaire GC ROTI®Cap-624, 25 m, 0,20 mm, 1,10 µm, 1 pièce(s)

1,2,4,5-Tetrachloro-3,6-dimethoxybenzene, 1g

5'-?O-?[Bis(4-?methoxyphenyl)phenylmethyl]?-2'-?O-methyl-?N-(2-?methyl-?1-?oxopropyl)guanosine, 97%, 25g